Esnocof 50 mg/2 mg Tablet
By Esnocof
Rx
10 Tablet in a Strip

Composition
Diethylcarbamazine(50mg) + Cetirizine(2mg)

Manufacturer - TTK Healthcare Ltd
6, Cathedral Road, Chennai - 600 086.

Expires on or after
September, 2026

liver
Esnocof 50 mg/2 mg Tablet is considered safe for use in individuals with liver disease. From the limited data available, it appears that altering the dosage of Esnocof 50 mg/2 mg Tablet may not be necessary for these patients. However, it is always best to consult with your healthcare provider for personalized advice and guidance regarding the use of this medication in relation to liver issues.

kidney
Esnocof 50 mg/2 mg Tablet needs caution in patients with kidney disease. Dosage adjustment may be necessary, consult your doctor. Not advised for severe kidney disease. End stage kidney disease patients may experience increased drowsiness with this medication.

alcohol
When taking Esnocof 50 mg/2 mg Tablet, it is important to note that it can increase drowsiness when used with alcohol.

driving
"Esnocof 50 mg/2 mg Tablet may cause drowsiness, dizziness, and impact alertness. Avoid driving if experiencing these side effects."

pregnancy
It is better to consult your doctor before using Esnocof 50 mg/2 mg Tablet during pregnancy.

breastfeeding
It is better to consult your doctor before using Esnocof 50 mg/2 mg Tablet.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | - |
| Action Class | - |
₹16.3
₹19.18
15.02% OFF
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 11-Feb-2025
